168 related articles for article (PubMed ID: 105013)
1. Enzyme replacement therapy by fibroblast transplantation: long-term biochemical study in three cases of Hunter's syndrome.
Dean MF; Stevens RL; Muir H; Benson PF; Button LR; Anderson RL; Boylston A; Mowbray J
J Clin Invest; 1979 Jan; 63(1):138-46. PubMed ID: 105013
[TBL] [Abstract][Full Text] [Related]
2. Mucopolysaccharidoses type II: enzymatic activity and quantitative and qualitative studies of urinary glycosaminoglycans in five patients.
Gallegos-Arreola MP; González-Noriega A; Zúñiga-González GM; Flores-Martínez SE; Morán Moguel MC; Figuera LE; Sánchez-Corona J
Arch Med Res; 1997; 28(1):91-4. PubMed ID: 9078594
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of amniotic epithelial membranes in patients with mucopolysaccharidoses.
Akle C; McColl I; Dean M; Adinolfi M; Brown S; Fensom AH; Marsh J; Welsh K
Exp Clin Immunogenet; 1985; 2(1):43-8. PubMed ID: 3939973
[TBL] [Abstract][Full Text] [Related]
4. Increased breakdown of glycosaminoglycans and appearance of corrective enzyme after skin transplants in Hunter syndrome.
Dean MF; Muir H; Benson PF; Button LR; Batchelor JR; Bewick M
Nature; 1975 Oct; 257(5527):609-12. PubMed ID: 126383
[No Abstract] [Full Text] [Related]
5. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes.
Toma L; Dietrich CP; Nader HB
Lab Invest; 1996 Dec; 75(6):771-81. PubMed ID: 8973472
[TBL] [Abstract][Full Text] [Related]
6. Enzyme replacement therapy by fibroblast transplantation in a case of Hunter syndrome.
Dean MF; Muir H; Benson PF; Button LR; Boylston A; Mowbray J
Nature; 1976 May; 261(5558):323-5. PubMed ID: 818571
[No Abstract] [Full Text] [Related]
7. Transplantation of fetal fibroblasts and correction of enzymatic deficiencies in patients with Hunter's or Hurler's disorders.
Adinolfi M; McColl I; Chase D; Fensom AH; Welsh K; Brown S; Marsh J; Thick M; Dean M
Transplantation; 1986 Sep; 42(3):271-4. PubMed ID: 3092412
[TBL] [Abstract][Full Text] [Related]
8. Hunter's syndrome: activity of iduronate sulfate sulfatase in the serum of pregnant heterozygotes.
Zlotogora J; Bach G
N Engl J Med; 1984 Aug; 311(5):331-2. PubMed ID: 6429538
[No Abstract] [Full Text] [Related]
9. Iduronate sulfatase activity in serum, lymphocytes, and fibroblasts--simplified diagnosis of the Hunter syndrome.
Liebaers I; Neufeld E
Pediatr Res; 1976 Aug; 10(8):733-6. PubMed ID: 821034
[TBL] [Abstract][Full Text] [Related]
10. Mucopolysaccharidosis type II (Hunter's syndrome) in Taiwan.
Su PH; Hwu WL; Chiang SC; Chiu PC; Lin SJ; Shu SG; Wang TR
J Formos Med Assoc; 1998 Mar; 97(3):186-90. PubMed ID: 9549269
[TBL] [Abstract][Full Text] [Related]
11. A defect in exodegradative pathways provides insight into endodegradation of heparan and dermatan sulfates.
Fuller M; Chau A; Nowak RC; Hopwood JJ; Meikle PJ
Glycobiology; 2006 Apr; 16(4):318-25. PubMed ID: 16377754
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation in Hunter syndrome: a preliminary report.
Warkentin PI; Dixon MS; Schafer I; Strandjord SE; Coccia PF
Birth Defects Orig Artic Ser; 1986; 22(1):31-9. PubMed ID: 3083885
[No Abstract] [Full Text] [Related]
13. Administration of iduronate sulfatase by plasma exchange to patients with the Hunter syndrome: a clinical study.
Brown FR; Hall CW; Neufeld EF; Munoz LL; Braine H; Andrzejewski S; Camargo EE; Mark SA; Richard JM; Moser HW
Am J Med Genet; 1982 Nov; 13(3):309-18. PubMed ID: 6817638
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary management of Hunter syndrome.
Muenzer J; Beck M; Eng CM; Escolar ML; Giugliani R; Guffon NH; Harmatz P; Kamin W; Kampmann C; Koseoglu ST; Link B; Martin RA; Molter DW; Muñoz Rojas MV; Ogilvie JW; Parini R; Ramaswami U; Scarpa M; Schwartz IV; Wood RE; Wraith E
Pediatrics; 2009 Dec; 124(6):e1228-39. PubMed ID: 19901005
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of a patient transplanted for Hunter's disease type IIB: a case report and literature review.
Bergstrom SK; Quinn JJ; Greenstein R; Ascensao J
Bone Marrow Transplant; 1994 Oct; 14(4):653-8. PubMed ID: 7858546
[TBL] [Abstract][Full Text] [Related]
16. A therapeutic trial of fresh plasma infusions over a period of 22 months in two siblings with Hunter's syndrome.
Yatziv S; Statter M; Abeliuk P; Meshulam M; Russel A
Isr J Med Sci; 1975 Aug; 11(8):802-8. PubMed ID: 809382
[TBL] [Abstract][Full Text] [Related]
17. Glycosaminoglycan degradation fragments in mucopolysaccharidosis I.
Fuller M; Meikle PJ; Hopwood JJ
Glycobiology; 2004 May; 14(5):443-50. PubMed ID: 14718373
[TBL] [Abstract][Full Text] [Related]
18. A substrate for direct measurement of L-iduronic acid 2-sulfate sulfatase.
Ginsberg LC; Di Ferrante DT; Di Ferrante N
Carbohydr Res; 1978 Jul; 64():225-35. PubMed ID: 98232
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of Hunter's disease. Enzyme study].
Schiavulli E; Loffredo L; Vecchio L; Giugliano R; Carfagnini N; Carlomagno S
Minerva Pediatr; 1977 Oct; 29(32):1937-46. PubMed ID: 413027
[No Abstract] [Full Text] [Related]
20. Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia.
Mullen CA; Thompson JN; Richard LA; Chan KW
Bone Marrow Transplant; 2000 May; 25(10):1093-7. PubMed ID: 10828871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
